Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.49 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.38 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1123673 | 0.98 | CYP3A4 (0.64) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL6313359 | 0.97 | CYP3A4 (0.62) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL852624 | 0.95 | CYP3A4 (0.60) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL9353575 | 0.94 | CYP3A4 (0.58) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| Pyrophosphoric Acid SCHEMBL27789794 | 0.92 | CYP3A4 (0.64) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL1123667 | 0.92 | CYP3A4 (0.68) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| Ammonia Solution, Strong SCHEMBL28201142 | 0.88 | CYP3A4 (0.68) | CYP3A4L3MBTL1TSHRATMTDP1 | |
| SCHEMBL27899239 | 0.88 | CYP3A4 (0.68) | CYP3A4L3MBTL1TSHRATMTDP1 | |
| Water SCHEMBL27931415 | 0.88 | CYP3A4 (0.68) | CYP3A4L3MBTL1TSHRATMTDP1 | |
| SCHEMBL116247 | 0.88 | CYP3A4 (0.72) | CYP3A4L3MBTL1TSHRATMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0459913-B1 | Composition comprising a novel alicyclic compound, a process for the preparation thereof, a curable composition, and a photo-polymerizable composition | DAICEL CHEM (JP) | 1994-07-27 | — | — | EP | claimed |
| US-11932723-B2 | High-purity 3,4-epoxycyclohexylmethyl methacrylate | DAICEL CORPORATION (JP) | 2024-03-19 | — | — | US | disclosed |
| US-20220089808-A1 | HIGH-PURITY 3,4-EPOXYCYCLOHEXYLMETHYL METHACRYLATE | DAICEL CORPORATION (JP) | 2022-03-24 | — | — | US | disclosed |
| WO-2020138052-A1 | HIGH-PURITY 3,4-EPOXYCYCLOHEXYLMETHYL METHACRYLATE | 株式会社ダイセル | 2020-07-02 | — | — | WO | disclosed |
| CN-1232483-C | Method and apparatus for separating and purifying conjugated diene | NIPPON ZEON CO (JP) | 2005-12-21 | — | — | CN | disclosed |
| US-6841061-B1 | Antigelling agent for hydrocarbon mixture containing conjugated diene and method of preventing clogging of apparatus for separating and purifying the mixture | ZEON CORPORATION (JP) | 2005-01-11 | — | — | US | disclosed |
| CN-1558885-A | Method and apparatus for separating and purifying conjugated diene | �ձ�������ʽ���� | 2004-12-29 | — | — | CN | disclosed |
| US-6770222-B1 | HYDROXYLAMINES AND PHOSPHORUS CONTAINING COMPOUND | NIPPON ZEON CO., LTD. (JP) | 2004-08-03 | — | — | US | disclosed |
| EP-1184444-A1 | ANTIGELLING AGENT FOR HYDROCARBON MIXTURE CONTAINING CONJUGATED DIENE AND METHOD OF PREVENTING CLOGGING OF APPARATUS FOR SEPARATING AND PURIFYING THE MIXTURE | Nippon Zeon Co., Ltd. (JP) | 2002-03-06 | — | — | EP | disclosed |
| EP-1061059-A1 | POLYMERIZATION-INHIBITING COMPOSITION, POLYMERIZATION INHIBITOR AND METHOD FOR INHIBITING POLYMERIZATION | NIPPON ZEON CO., LTD. (JP) | 2000-12-20 | — | — | EP | disclosed |
| US-5378736-A | Epoxidized polylactone, coatings | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-01-03 | — | — | US | disclosed |
| EP-0466596-B1 | Lactone-modified alicyclic composition, and an epoxidized composition thereof | DAICEL CHEM (JP) | 1994-10-05 | — | — | EP | disclosed |
| US-5338879-A | Useful in coating compositions; curable | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1994-08-16 | — | — | US | disclosed |
| EP-0459913-B1 | Composition comprising a novel alicyclic compound, a process for the preparation thereof, a curable composition, and a photo-polymerizable composition | DAICEL CHEM (JP) | 1994-07-27 | — | — | EP | disclosed |
| EP-0540027-A2 | Compositions, expoxidized compositions, a heat-curable resin composition, an epoxy resin composition, radically polymerized composition, a curable resin composition and a polymer having epoxy groups | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1993-05-05 | — | — | EP | disclosed |
| US-5198509-A | Curable composition with epoxy groups and esters | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1993-03-30 | — | — | US | disclosed |
| EP-0529197-A1 | A process for the preparation of a purified 3,4-epoxycyclohexyl-methyl (meth)acrylate and a stabilised composition thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1993-03-03 | — | — | EP | disclosed |
| US-5169965-A | Heat-curable or photocurable compounds; coatings; toughness; finishing; low-temperature cure | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1992-12-08 | — | — | US | disclosed |
| EP-0466596-A2 | Lactone-modified alicyclic composition, and an epoxidized composition thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1992-01-15 | — | — | EP | disclosed |
| EP-0459913-A2 | Composition comprising a novel alicyclic compound, a process for the preparation thereof, a curable composition, and a photo-polymerizable composition | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089808-A1 | HIGH-PURITY 3,4-EPOXYCYCLOHEXYLMETHYL METHACRYLATE | MEP1A, MEP1B, FTO | CYP3A4 717/4885L3MBTL1 1391/4885LPAR3 3987/4885 |
| US-11932723-B2 | High-purity 3,4-epoxycyclohexylmethyl methacrylate | MEP1A, MEP1B, FTO | CYP3A4 717/4885L3MBTL1 1391/4885LPAR3 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.